Related references
Note: Only part of the references are listed.Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-beta Burden in Down Syndrome
Patrick J. Lao et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome
Amanda Sinai et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome
Panagiotis Zis et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Down syndrome, beta-amyloid and neuroimaging
Elizabeth Head et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome
Natalie Neale et al.
NEUROIMAGE-CLINICAL (2018)
The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts
Zoe Arvanitakis et al.
BRAIN PATHOLOGY (2017)
Estimation of the number of people with Down syndrome in the United States
Gert de Graaf et al.
GENETICS IN MEDICINE (2017)
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
Michael S. Rafii et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
Gargi Banerjee et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome
Sigan L. Hartley et al.
NEUROBIOLOGY OF AGING (2017)
Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan
Harry LeVine et al.
NEUROBIOLOGY OF AGING (2017)
Mortality patterns and risk among older men and women with intellectual disability: a Swedish national retrospective cohort study
Nawi Ng et al.
BMC GERIATRICS (2017)
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Elizabeth Head et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease
Maria Carmona-Iragui et al.
ALZHEIMERS & DEMENTIA (2017)
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
Elizabeth Head et al.
CURRENT ALZHEIMER RESEARCH (2016)
Mortality Among Adults With Intellectual Disability in England: Comparisons With the General Population
Fay J. Hosking et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2016)
Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study
Zoe Arvanitakis et al.
LANCET NEUROLOGY (2016)
1H-MRS metabolites in adults with Down syndrome: Effects of dementia
A. -L. Lin et al.
NEUROIMAGE-CLINICAL (2016)
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia
Marwan N. Sabbagh et al.
ALZHEIMERS & DEMENTIA (2015)
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome
Michael S. Rafii et al.
Frontiers in Behavioral Neuroscience (2015)
Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1Η MRS) in children with Down syndrome
Joanna Śmigielska-Kuzia et al.
Pharmacological Reports (2014)
What have novel imaging techniques revealed about metabolism in the aging brain?
Ai-Ling Lin et al.
FUTURE NEUROLOGY (2014)
Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy (1H MRS)
Giles M. Y. Tan et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2014)
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain
Linda Chang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Biomarker Modeling of Alzheimer's Disease
Clifford R. Jack et al.
NEURON (2013)
Cerebral amyloid angiopathy impact on endothelium
Lea Tenenholz Grinberg et al.
EXPERIMENTAL GERONTOLOGY (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Cerebral amyloid angiopathy in the elderly
Anand Viswanathan et al.
ANNALS OF NEUROLOGY (2011)
Down syndrome with and without dementia: An in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease
Melissa Lamar et al.
NEUROIMAGE (2011)
Synaptojanin-1 plays a key role in astrogliogenesis: possible relevance for Down's syndrome
F. Herrera et al.
CELL DEATH AND DIFFERENTIATION (2009)
Neuroimaging of individuals with Down's syndrome at-risk for dementia: Evidence for possible compensatory events
R. J. Haier et al.
NEUROIMAGE (2008)
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
W. Jagust et al.
NEUROLOGY (2007)
Neuroanatomy of Down syndrome in vivo:: A model of preclinical Alzheimer's disease
Stefan J. Teipel et al.
BEHAVIOR GENETICS (2006)
Pattern of increased cerebral FDG uptake in Down syndrome patients
Z Lengyel et al.
PEDIATRIC NEUROLOGY (2006)
Hippocampal myo-inositol and cognitive ability in adults with Down syndrome -: An in vivo proton magnetic resonance spectroscopy study
F Beacher et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
RJ Haier et al.
NEUROLOGY (2003)
Parallel compensatory and pathological events associated with Tau pathology in middle aged individuals with Down Syndrome
E Head et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Genetic and host factors for dementia in Down's syndrome
N Schupf
BRITISH JOURNAL OF PSYCHIATRY (2002)
Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome
DHS Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: Normal development, aging, dementia, and stroke
DHS Silverman et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Share Paper
